Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Radiation Safety

An Instrumented Shield System for Calibration of Technetium-99m

S.G. Prussin, S.M. Lane, D.R. Kania, S. Han, J.E. Trebes, H. Spracklen, H. Moore, K.G. Burkes and W. Porter
Journal of Nuclear Medicine Technology September 1995, 23 (3) 202-208;
S.G. Prussin
Sunol Technologies, Inc., Sunol, California; DuPont Radiopharmaceutical Division, DuPont Merck Pharmaceutical Co., North Billerica, Massachusetts; Syncor International Corporation, Berkeley, California; and Nuclear Medicine Department, Henry Ford Hospital, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.M. Lane
Sunol Technologies, Inc., Sunol, California; DuPont Radiopharmaceutical Division, DuPont Merck Pharmaceutical Co., North Billerica, Massachusetts; Syncor International Corporation, Berkeley, California; and Nuclear Medicine Department, Henry Ford Hospital, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.R. Kania
Sunol Technologies, Inc., Sunol, California; DuPont Radiopharmaceutical Division, DuPont Merck Pharmaceutical Co., North Billerica, Massachusetts; Syncor International Corporation, Berkeley, California; and Nuclear Medicine Department, Henry Ford Hospital, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Han
Sunol Technologies, Inc., Sunol, California; DuPont Radiopharmaceutical Division, DuPont Merck Pharmaceutical Co., North Billerica, Massachusetts; Syncor International Corporation, Berkeley, California; and Nuclear Medicine Department, Henry Ford Hospital, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.E. Trebes
Sunol Technologies, Inc., Sunol, California; DuPont Radiopharmaceutical Division, DuPont Merck Pharmaceutical Co., North Billerica, Massachusetts; Syncor International Corporation, Berkeley, California; and Nuclear Medicine Department, Henry Ford Hospital, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Spracklen
Sunol Technologies, Inc., Sunol, California; DuPont Radiopharmaceutical Division, DuPont Merck Pharmaceutical Co., North Billerica, Massachusetts; Syncor International Corporation, Berkeley, California; and Nuclear Medicine Department, Henry Ford Hospital, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Moore
Sunol Technologies, Inc., Sunol, California; DuPont Radiopharmaceutical Division, DuPont Merck Pharmaceutical Co., North Billerica, Massachusetts; Syncor International Corporation, Berkeley, California; and Nuclear Medicine Department, Henry Ford Hospital, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K.G. Burkes
Sunol Technologies, Inc., Sunol, California; DuPont Radiopharmaceutical Division, DuPont Merck Pharmaceutical Co., North Billerica, Massachusetts; Syncor International Corporation, Berkeley, California; and Nuclear Medicine Department, Henry Ford Hospital, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Porter
Sunol Technologies, Inc., Sunol, California; DuPont Radiopharmaceutical Division, DuPont Merck Pharmaceutical Co., North Billerica, Massachusetts; Syncor International Corporation, Berkeley, California; and Nuclear Medicine Department, Henry Ford Hospital, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Objective: The elution of 99mTc from commercial 99Mo- 99mTc generators and the subsequent calibration of both the bulk activity and 99Mo impurity can lead to significant extremity dose to the fingers, hands and forearms. The dose arises primarily from the need to handle intense, unshielded sources when calibrations are performed with re-entry type ion chambers. The objective of this study was to develop a dose calibration system that incorporated a fully-instrumented shield for assay of gamma-emitting radioisotopes without the need for handling unshielded sources.

Methods: Prototype instrumented shield systems were tested in routine calibration of 99mTc eluted from commercial 99Mo-99mTc generators to determine the quality and reproducibility of measurements. Pilot experiments were conducted to compare the extremity dose burdens from calibrations with the instrumented shield system and with standard re-entry type ionization chambers.

Results: Decay measurements with 99mTc show that the instrumented shield system provides calibrations with less than 2% systematic nonlinearity for sources of 5 x 102-1.5 x 105 MBq (15–4000 mCi). Systematic errors from source geometry variation, including changes in eluate volumes from 5–21 ml, are less than 1%. Typical calibration procedures with a re-entry type ion chamber produce dose burdens to the fingers of (2.7–10.8) x 10-4 mSv GBq-1 (1–4 mRem Ci-1) of 99mTc handled.

Conclusion: When calibrations were performed with the instrumented shield system, the dose received could not be distinguished within the sensitivity limit of TLD finger rings used in the measurements.

  • dose calibration system
  • extremity exposure
  • radioisotope generator elution
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 23 (3)
Journal of Nuclear Medicine Technology
Vol. 23, Issue 3
September 1, 1995
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An Instrumented Shield System for Calibration of Technetium-99m
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
An Instrumented Shield System for Calibration of Technetium-99m
S.G. Prussin, S.M. Lane, D.R. Kania, S. Han, J.E. Trebes, H. Spracklen, H. Moore, K.G. Burkes, W. Porter
Journal of Nuclear Medicine Technology Sep 1995, 23 (3) 202-208;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
An Instrumented Shield System for Calibration of Technetium-99m
S.G. Prussin, S.M. Lane, D.R. Kania, S. Han, J.E. Trebes, H. Spracklen, H. Moore, K.G. Burkes, W. Porter
Journal of Nuclear Medicine Technology Sep 1995, 23 (3) 202-208;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Diagnostic Reference Levels in PET Imaging at Chulabhorn Hospital, Thailand
  • Experiences of Nuclear Medicine Technologists Working in PET/CT Facilities in Gauteng Province, South Africa
  • Establishment of National Diagnostic Reference Levels for Administered Activity in Diagnostic Nuclear Medicine in Thailand
Show more RADIATION SAFETY

Similar Articles

Keywords

  • dose calibration system
  • extremity exposure
  • radioisotope generator elution
SNMMI

© 2025 SNMMI

Powered by HighWire